| Financial Year |
March 31 2023 |
| Monetary Funds |
2,317,298,811.60 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
45,130,123.06 |
| Advances to Suppliers |
50,338,510.13 |
| Other Receivables |
23,847,469.54 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
601,759,966.01 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
45,529,529.52 |
| Total Current Assets |
3,096,646,341.95 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
16,059,698,505.66 |
| Investment Properties |
-- |
| Fixed Assetes |
3,983,025,702.64 |
| Under-construction Projects |
985,260,388.49 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
280,891,316.01 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
25,660,952.83 |
| Other Non-Current Assets |
80,676,876.71 |
| Sub-Total of Non-Current Assets |
21,465,213,742.34 |
| Total Assets |
24,561,860,084.29 |
| Short-Term Loans |
3,024,924,891.78 |
| Trading Financial liabilities |
-- |
| Notes Payable |
2,150,250,000.00 |
| Accounts Payable |
553,059,844.32 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
64,966,196.55 |
| Taxes Payable |
8,201,912.85 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
29,982,411.82 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
521,820,168.08 |
| Other Current Liabilities |
52,041,109.01 |
| Sub-Total of Current Liabilities |
6,805,638,964.03 |
| Long-term Loans |
2,216,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
37,120,000.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
107,795.24 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
2,333,728,349.86 |
| Total Liabilities |
9,139,367,313.89 |
| Paid-In Capital(Or Share Stock) |
2,562,121,154.00 |
| Capital Surplus |
7,057,730,809.36 |
| Surplus Reserve |
915,452,236.33 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
4,687,621,074.97 |
| Minority Stockholder's Interest |
216,244,132.13 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
15,206,248,638.27 |
| Owner's Equity（Stockholder's Equity） |
15,422,492,770.40 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
24,561,860,084.29 |
